COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE
Product details
Registration number: SIN17053P
Classification: Prescription Only
Active ingredients:
- Famtozinameran
- Tozinameran
Strength:
- 1.5 μg/dose
- 1.5 μg/dose
Dosage form: INJECTION
Route: INTRAMUSCULAR
Registrant: BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD.
ATC code: J07BN01
HSA approval date: 25 July 2024
Manufacturer(s): Pfizer Manufacturing Belgium NV
Manufacturing country/countries: BELGIUM
What are the HSA registration number and classification for COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17053P
Classification: Prescription Only
What active ingredients and strength are recorded for COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Famtozinameran
- Tozinameran
Strength:
- 1.5 μg/dose
- 1.5 μg/dose
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAMUSCULAR
Who is the recorded registrant for COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE?
According to the HSA dataset updated 7 August 2026:
Registrant: BIONTECH PHARMACEUTICALS ASIA PACIFIC PTE. LTD.
Which manufacturers and countries are listed for COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Pfizer Manufacturing Belgium NV
Manufacturing country/countries: BELGIUM
Where can I look up COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17053P or the exact product name COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE. The general register link does not preselect this product.
What are the source dates for this COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17053P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)